Comparative analysis of MS outcomes in natalizumab treated patients using a novel three way multinomial propensity score match

Spelman T., Pellegrini F., Zhang A., Trojano M., Wiendl H., Kappos L., ...Daha Fazla

32nd The European Committee for Treatment and Research in Multiple Sclerosis(ECTRIMS), 14 - 17 Eylül 2016

  • Yayın Türü: Bildiri
  • Ondokuz Mayıs Üniversitesi Adresli: Evet